Novartis Provides Update on Use and Safety of Beovu in Patients With Wet AMD

After the American Society of Retinal Specialists (ASRS) shared a note with its membership warning of vision-threatening cases of occlusive retinal vasculitis of wet AMD drug Beovu, Novartis issued a press release stating it stands behind the safety and efficacy of Beovu when used as indicated … Source: eyewire